Martire Maria, D'Amico Monia, Panza Elisabetta, Miceli Francesco, Viggiano Davide, Lavergata Francesco, Iannotti Fabio Arturo, Barrese Vincenzo, Preziosi Paolo, Annunziato Lucio, Taglialatela Maurizio
Institute of Pharmacology, School of Medicine, Catholic University of S. Heart, Rome, Italy.
J Neurochem. 2007 Jul;102(1):179-93. doi: 10.1111/j.1471-4159.2007.04562.x. Epub 2007 Apr 16.
KCNQ2 and KCNQ3 subunits encode for the muscarinic-regulated current (I(KM)), a sub-threshold voltage-dependent K+ current regulating neuronal excitability. In this study, we have investigated the involvement of I(KM) in dopamine (DA) release from rat striatal synaptosomes evoked by elevated extracellular K+ concentrations ([K+]e) and by muscarinic receptor activation. [3H]dopamine ([3H]DA) release triggered by 9 mmol/L [K+]e was inhibited by the I(KM) activator retigabine (0.01-30 micromol/L; Emax = 54.80 +/- 3.85%; IC50 = 0.50 +/- 0.36 micromol/L). The I(KM) blockers tetraethylammonium (0.1-3 mmol/L) and XE-991 (0.1-30 micromol/L) enhanced K+-evoked [3H]DA release and prevented retigabine-induced inhibition of depolarization-evoked [3H]DA release. Retigabine-induced inhibition of K+-evoked [3H]DA release was also abolished by synaptosomal entrapment of blocking anti-KCNQ2 polyclonal antibodies, an effect prevented by antibody pre-absorption with the KCNQ2 immunizing peptide. Furthermore, the cholinergic agonist oxotremorine (OXO) (1-300 micromol/L) potentiated 9 mmol/L [K+]e-evoked [3H]DA release (Emax = 155 +/- 9.50%; EC50 = 25 +/- 1.80 micromol/L). OXO (100 micromol/L)-induced [3H]DA release enhancement was competitively inhibited by pirenzepine (1-10 nmol/L) and abolished by the M3-preferring antagonist 4-diphenylacetoxy N-methylpiperidine methiodide (1 micromol/L), but was unaffected by the M1-selective antagonist MT-7 (10-100 nmol/L) or by Pertussis toxin (1.5-3 microg/mL), which uncouples M2- and M4-mediated responses. Finally, OXO-induced potentiation of depolarization-induced [3H]DA release was not additive to that produced by XE-991 (10 micromol/L), was unaffected by retigabine (10 micromol/L), and was abolished by synaptosomal entrapment of anti-KCNQ2 antibodies. Collectively, these findings indicate that, in rat striatal nerve endings, I(KM) channels containing KCNQ2 subunits regulate depolarization-induced DA release and that I(KM) suppression is involved in the reinforcement of depolarization-induced DA release triggered by the activation of pre-synaptic muscarinic heteroreceptors.
KCNQ2和KCNQ3亚基编码毒蕈碱调节电流(I(KM)),这是一种阈下电压依赖性钾离子电流,可调节神经元兴奋性。在本研究中,我们研究了I(KM)在细胞外钾离子浓度升高([K+]e)和毒蕈碱受体激活所诱发的大鼠纹状体突触体多巴胺(DA)释放中的作用。9 mmol/L [K+]e触发的[3H]多巴胺([3H]DA)释放受到I(KM)激活剂瑞替加滨(0.01 - 30 μmol/L;Emax = 54.80 +/- 3.85%;IC50 = 0.50 +/- 0.36 μmol/L)的抑制。I(KM)阻滞剂四乙铵(0.1 - 3 mmol/L)和XE - 991(0.1 - 30 μmol/L)增强了钾离子诱发的[3H]DA释放,并阻止了瑞替加滨对去极化诱发的[3H]DA释放的抑制作用。瑞替加滨对钾离子诱发的[3H]DA释放的抑制作用也被封闭抗KCNQ2多克隆抗体的突触体截留所消除,而抗体与KCNQ2免疫肽预吸附可防止这种作用。此外,胆碱能激动剂氧化震颤素(OXO)(1 - 300 μmol/L)增强了9 mmol/L [K+]e诱发的[3H]DA释放(Emax = 155 +/- 9.50%;EC50 = 25 +/- 1.80 μmol/L)。OXO(100 μmol/L)诱导的[3H]DA释放增强被哌仑西平(1 - 10 nmol/L)竞争性抑制,并被M3选择性拮抗剂4 - 二苯基乙酰氧基N - 甲基哌啶甲碘化物(1 μmol/L)消除,但不受M1选择性拮抗剂MT - 7(10 - 100 nmol/L)或百日咳毒素(1.5 - 3 μg/mL)的影响,百日咳毒素可使M2和M4介导的反应解偶联。最后,OXO诱导的去极化诱导的[3H]DA释放增强与XE - 991(10 μmol/L)产生的增强作用无相加性,不受瑞替加滨(10 μmol/L)影响,并被抗KCNQ2抗体的突触体截留所消除。总体而言,这些发现表明,在大鼠纹状体神经末梢中,含有KCNQ2亚基的I(KM)通道调节去极化诱导的DA释放,并且I(KM)的抑制参与了突触前毒蕈碱异受体激活所触发的去极化诱导的DA释放的增强。